🇧🇷 KISUNLA in Brazil

KISUNLA (DONANEMAB-AZBT) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

KISUNLA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Brazil

Frequently asked questions

Is KISUNLA approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for KISUNLA in Brazil?

ELI LILLY CO is the originator. The local marketing authorisation holder may differ — check the official source linked above.